ÍøºìºÚÁÏ

Skip to main content
(352) 273-8740

Ali Ataya, MD : Research

Critical Care Medicine Specialist, Pulmonologist (Lung Specialist)

Photo of Ali Ataya
(352) 273-8740 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Dyspnea , 10 publications
  • Pulmonary Alveolar Proteinosis , 4 publications
  • Lymphangioleiomyomatosis , 4 publications
  • Fever , 4 publications

Research activity

122 publications

396 citations

Why is this important?

Active clinical trials

United therapeutics 301

Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World ÍøºìºÚÁÏ Organization (WHO)…

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All
Sapphire

This study aims to evaluate the efficacy and safety of inhaled treprostinil in subjects with sarcoidosis-associated interstitial lung disease and pulmonary hypertension.

Investigator
Ali Ataya
Status
Accepting Candidates
Ages
18 Years - 99 Years
Sexes
All

My publications

122 publications

2022

A 43-Year-Old Woman With Pleuritic Chest Pain, Shortness of Breath, and Weakness of All Extremities

CHEST

2022

Advanced airway management and respiratory care in decompensated pulmonary hypertension.

Heart failure reviews

•

2022

COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition.

Chest

•

2022

Letter to the Editor concerning A study on infectivity of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) carriers by Gao et al.

Respiratory medicine

•

2022

Opportunistic Infection Associated With Elevated GM-CSF Autoantibodies: A Case Series and Review of the Literature.

Open forum infectious diseases

•